 G70 |
 |
Myasthenia gravis and other myoneural disorders  |
| |
|
| |
| G70.0 |
|
Myasthenia gravis |
| |
 G70.00 |
|
Myasthenia gravis without (acute) exacerbation |
| |
|
| | |
| G70.01 |
|
Myasthenia gravis with (acute) exacerbation |
| |
| Myasthenia gravis in crisis |
|
| |
| |
| G70.1 |
|
Toxic myoneural disorders |
| |
| CodeFirst |
(T51-T65) to identify toxic agent
|
|
|
| |
| G70.2 |
|
Congenital and developmental myasthenia |
|
| |
| G70.8 |
|
Other specified myoneural disorders |
| |
| G70.80 |
|
Lambert-Eaton syndrome, unspecified |
| |
| Lambert-Eaton syndrome NOS |
|
| | |
| G70.81 |
|
Lambert-Eaton syndrome in disease classified elsewhere |
| |
| CodeFirst |
underlying disease
|
| Excludes1 |
Lambert-Eaton syndrome in neoplastic disease (G73.1)
|
| nonPrimary |
Yes
|
|
| | |
| G70.89 |
|
Other specified myoneural disorders |
| |
| |
| G70.9 |
|
Myoneural disorder, unspecified |
|